IncFact
Company Profiles: Revenue, Growth, Competition

Cingulate Therapeutics Revenue, Growth & Competitor Profile

Last updated:

Company Awards

Brain Power (IP)
Patent/Trademark IP
 

Company Profile & Annual Report for Cingulate Therapeutics

Access the complete profile.

Cingulate Therapeutics Fast Facts

Revenue$10 - $100 million    See Exact Annual Revenue
Employees10 - 100Exact Company Size
Primary Industry325411 Medicinal & Botanical Manufacturing
Additional NAICS Codes325412 Pharmaceutical Preparation Manufacturing
Address1901 W 47th Place
Kansas City, KS 66205

Note: Revenues for privately held companies are statistical evaluations.


Cingulate Therapeutics's Annual Report & Profile shows critical firmographic facts:
  • What is the company's size? (Annual sales and employees)
  • What industry is the company in?
    • Cingulate Therapeutics is classified as operating in the Medicinal & Botanical Manufacturing industry, NAICS Code 325411.

Cingulate Therapeutics Annual Revenue and Growth Rate

Cingulate Therapeutics Revenue Est.
($ Million)
Growth Rate (%)# Employees
2023 $10 - $100 million

Details in Premium Report
2022
2021
2020
2019


1-Year Growth Rate:
3-Year Growth Rate (CAGR):
Premium Report

Note: Cingulate Therapeutics's revenues are gauged from an analysis of company filings.



Cingulate Therapeutics's Income Statement (based on Industry Averages)

Cingulate Therapeutics P&L$ Millions
Revenue (Sales) Cingulate Therapeutics Premium Report
Cost of Goods Sold
Gross Profit

Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit
 


Trademark Applications

Trademark applications show the products and services that Cingulate Therapeutics is developing and marketing. Cingulate Therapeutics doesn't have any recent trademark applications, indicating Cingulate Therapeutics is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark Date
TYMPREZI
Pharmaceutical preparations for the treatment of attention deficit hyperactivity disorder (ADHD)
02/03/2020
TAYLERZA
Pharmaceutical preparations for the treatment of attention deficit hyperactivity disorder (ADHD)
02/03/2020
IVOQUS
Pharmaceutical preparations for the treatment of attention deficit hyperactivity disorder (ADHD)
02/03/2020

See all trademarks and details in the Full Report.


Market Share of Cingulate Therapeutics's Largest Competitors

A competitive analysis shows these companies are in the same general field as Cingulate Therapeutics, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company HeadquartersRevenue ($ MM)
XYMOGENOrlando, FL100 
AVANTI NUTRITIONAL LABORATORIESMiami Lakes, FL37 
NUTRITION FORMULATORSMiramar, FL36 
RTPRCabot, AR33 
INTEGRATED BOTANICSFort Worth, TX29 
COSMAX NBT USAGarland, TX29 
CJB INDUSTRIESValdosta, GA28 
ALTERNATIVE LABORATORIESNaples, FL28 
S&B PHARMAAzusa, CA28 




Nearby Competitors

These companies are similar in business line and location to Cingulate Therapeutics. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company HeadquartersRevenue ($ MM)
CEVA U.S. HOLDINGSLenexa, KS100 
SPARHAWK LABORATORIESLenexa, KS16 
B.F. ASCHERLenexa, KS6 
GEORGE KING BIO MEDICALOverland Park, KS3 
CINGULATE THERAPEUTICSKansas City, KS2 
KC EXTRACTION SERVICESLenexa, KS2 




Future Competition: Cingulate Therapeutics's Fastest Growing Competitors

These companies are in the same general field as Cingulate Therapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

CompanyRevenue ($ MM)
Cingulate Therapeutics Competitors